Federal regulators announced Monday that all GLP-1 medications - including Ozempic, Wegovy, Zepbound and Mounjaro - must now carry a label warning about a rare eye condition that can cause permanent FDA Links Ozempic-Class Drugs to Rare Optic Nerve DamageRead more
Pharmacies and medicines
Croatian Pharmacy Survey Finds Most Fail to Give Accurate Anti-Doping Guidance
A simulated-patient study of community pharmacies in Croatia found that only 10% gave fully accurate, World Anti-Doping Agency-consistent advice when asked about a common asthma medication's use in Croatian Pharmacy Survey Finds Most Fail to Give Accurate Anti-Doping GuidanceRead more
Compounding Pharmacy's Sterility Lapses Trigger Nationwide Tirzepatide Recall
Federal regulators say a North Carolina compounding pharmacy, Apothecary Pharma, has pulled 23 vials of injectable drugs from the market over concerns they may not be sterile. The recall covers 22 Compounding Pharmacy's Sterility Lapses Trigger Nationwide Tirzepatide RecallRead more